Basilea appoints Ronald Scott as CEO to succeed Anthony Man and expands ...
| 10 Dec 2012 21:06 | Equities.com |
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the fully integrated research and development operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd.